FindTrial
Sign In

A randomized, double-blind, placebo-controlled, phase 2 study of S-033188 in otherwise healthy adult patients with influenza

A randomized, double-blind, placebo-controlled, phase 2 study of S-033188 in otherwise healthy adult patients with influenza

Status
Unknown
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT2080223036
Enrollment
Unknown
Registered
2015-12-03
Start date
2015-12-03
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Influenza A/B virus infection

Interventions

investigational material(s) Generic name etc : S-033188 INN of investigational material : Therapeutic category code : 625 Anti-virus agents Dosage and Administration for Investigational material : Or

Sponsors

Shionogi & Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients confirmed with influenza virus infection and within 48 hours from onset.

Exclusion criteria

Exclusion criteria: -Patients with severe, complicated, or progressive illness to require in-hospital care -Patients with high risk factors. -Patients with concurrent infections requiring antimicrobial therapy. etc.

Design outcomes

Primary

MeasureTime frame
Efficacy, safety—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026